Market Cap 1.56B
Revenue (ttm) 1.90B
Net Income (ttm) 235.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 12.37%
Debt to Equity Ratio 1.00
Volume 9,413,400
Avg Vol 12,129,322
Day's Range N/A - N/A
Shares Out 98.28M
Stochastic %K 62%
Beta 0.46
Analysts Sell
Price Target $22.83

Company Profile

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dy...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 274 4000
Address:
215 First Street, Suite 415, Cambridge, United States
TradeOrGoHome
TradeOrGoHome Aug. 3 at 12:26 PM
If $SRPT doesn’t hit $60 by end of year, I will delete my account and quit the market entirely. 5 months to go.
0 · Reply
Crash_Bash
Crash_Bash Aug. 3 at 12:15 PM
$SRPT wtf is wrong with people these days? Now we base a billion follar company with 2b rev on reddit comments? Thats how financial markets are judged now?? And we wonder why people lose money....
0 · Reply
Trademotions
Trademotions Aug. 3 at 11:52 AM
$SRPT massive disconnection between the company intrinsic value (even if Elevidys was to be worth zero) and the current share price, will loading up more on Monday, GLTA
0 · Reply
valport
valport Aug. 3 at 10:22 AM
$SRPT buy before wednsday last chance
0 · Reply
Publicola29
Publicola29 Aug. 3 at 10:20 AM
$SRPT anytime you see someone trying to compare Sarepta to Bluebird Bio, keep in mind that Blue did $83M in revenue last year and that was a great year for them, SRPT did $2B and currently has a market cap of $1.5B
1 · Reply
Frogsolf
Frogsolf Aug. 3 at 10:18 AM
$SRPT We all know what it usually means when a company lays off some employees only to start hiring again shortly after. You need a justification to let certain people go — and this is actually a good sign.
0 · Reply
bluffmeariver
bluffmeariver Aug. 3 at 8:47 AM
$SRPT https://www.reddit.com/r/biotech/s/yA1mQN72pU Aton of berish comments on reddit
4 · Reply
SannieVerraderlijk
SannieVerraderlijk Aug. 3 at 8:32 AM
$SRPT https://www.wsj.com/opinion/fdas-reversal-on-gene-therapy-helps-my-son-241cac7b
0 · Reply
Hoekie12
Hoekie12 Aug. 3 at 7:27 AM
$SRPT This happens when you hire students to make bearish posts 🫣😂😂
0 · Reply
Hoekie12
Hoekie12 Aug. 3 at 7:26 AM
$CAPR $SRPT Trump fired the director who withdraw the drugs. Parents and conservative organizations want to get this back in the market. Soon full access to the market again 👍
1 · Reply
Latest News on SRPT
Opinion | On Sarepta, a Welcome FDA Reversal

Jul 29, 2025, 5:48 PM EDT - 4 days ago

Opinion | On Sarepta, a Welcome FDA Reversal


SRPT Rallies on FDA Green Light: A New Bottom for the Stock?

Jul 29, 2025, 2:06 PM EDT - 4 days ago

SRPT Rallies on FDA Green Light: A New Bottom for the Stock?


Sarepta: SRPT Stock To $40?

Jul 29, 2025, 9:00 AM EDT - 4 days ago

Sarepta: SRPT Stock To $40?


Sarepta Stock Just Soared 45%. Here's Why.

Jul 29, 2025, 5:01 AM EDT - 5 days ago

Sarepta Stock Just Soared 45%. Here's Why.


Sarepta Therapeutics: Beaten Down, But Not Out

Jul 28, 2025, 4:17 AM EDT - 6 days ago

Sarepta Therapeutics: Beaten Down, But Not Out


Opinion | The Sarepta Mugging and Drug Innovation

Jul 27, 2025, 1:37 PM EDT - 6 days ago

Opinion | The Sarepta Mugging and Drug Innovation


InnovationRx: Sarepta Blinks In Showdown With FDA

Jul 23, 2025, 12:10 PM EDT - 10 days ago

InnovationRx: Sarepta Blinks In Showdown With FDA


Sarepta to pause gene therapy Elevidys shipments in US

Jul 21, 2025, 8:13 PM EDT - 12 days ago

Sarepta to pause gene therapy Elevidys shipments in US


HC Wainwright's Kapoor talks if Sarepta shares could hit $0

Jul 21, 2025, 6:16 PM EDT - 12 days ago

HC Wainwright's Kapoor talks if Sarepta shares could hit $0


Sarepta Faces Regulatory Showdown As Analysts Cut Price Targets

Jul 21, 2025, 3:06 PM EDT - 12 days ago

Sarepta Faces Regulatory Showdown As Analysts Cut Price Targets


TradeOrGoHome
TradeOrGoHome Aug. 3 at 12:26 PM
If $SRPT doesn’t hit $60 by end of year, I will delete my account and quit the market entirely. 5 months to go.
0 · Reply
Crash_Bash
Crash_Bash Aug. 3 at 12:15 PM
$SRPT wtf is wrong with people these days? Now we base a billion follar company with 2b rev on reddit comments? Thats how financial markets are judged now?? And we wonder why people lose money....
0 · Reply
Trademotions
Trademotions Aug. 3 at 11:52 AM
$SRPT massive disconnection between the company intrinsic value (even if Elevidys was to be worth zero) and the current share price, will loading up more on Monday, GLTA
0 · Reply
valport
valport Aug. 3 at 10:22 AM
$SRPT buy before wednsday last chance
0 · Reply
Publicola29
Publicola29 Aug. 3 at 10:20 AM
$SRPT anytime you see someone trying to compare Sarepta to Bluebird Bio, keep in mind that Blue did $83M in revenue last year and that was a great year for them, SRPT did $2B and currently has a market cap of $1.5B
1 · Reply
Frogsolf
Frogsolf Aug. 3 at 10:18 AM
$SRPT We all know what it usually means when a company lays off some employees only to start hiring again shortly after. You need a justification to let certain people go — and this is actually a good sign.
0 · Reply
bluffmeariver
bluffmeariver Aug. 3 at 8:47 AM
$SRPT https://www.reddit.com/r/biotech/s/yA1mQN72pU Aton of berish comments on reddit
4 · Reply
SannieVerraderlijk
SannieVerraderlijk Aug. 3 at 8:32 AM
$SRPT https://www.wsj.com/opinion/fdas-reversal-on-gene-therapy-helps-my-son-241cac7b
0 · Reply
Hoekie12
Hoekie12 Aug. 3 at 7:27 AM
$SRPT This happens when you hire students to make bearish posts 🫣😂😂
0 · Reply
Hoekie12
Hoekie12 Aug. 3 at 7:26 AM
$CAPR $SRPT Trump fired the director who withdraw the drugs. Parents and conservative organizations want to get this back in the market. Soon full access to the market again 👍
1 · Reply
Initiator1
Initiator1 Aug. 3 at 7:08 AM
$SRPT And if your child has a 0.2% chance of dying due to the drug vs definitely dying in a couple of years, what would you choose?
1 · Reply
bluffmeariver
bluffmeariver Aug. 3 at 7:00 AM
$SRPT okay just imagine that your child is born with this disease. Just tell me would you immediately ask for this drug or not Enough said
1 · Reply
Darrel_Lhick
Darrel_Lhick Aug. 3 at 6:20 AM
$SRPT Gene therapy is the closest thing to a cure for anything thatsever been. This os exciting stuff. Not just for DMD bit all sorts of gentic issues. Benefits of Elevidys Compared to Other Options One-Time Treatment: Benefit: Elevidys is administered as a single intravenous infusion, eliminating the need for ongoing treatments. This contrasts with corticosteroids and exon-skipping therapies, which require daily or weekly administration, respectively, posing a significant burden on patients and families. 
2 · Reply
broke_millionaire
broke_millionaire Aug. 3 at 3:55 AM
$SRPT shorts
0 · Reply
RuskiGambler
RuskiGambler Aug. 3 at 3:17 AM
$SRPT Have patience friends. We’re on the way back to $100
0 · Reply
TradeOrGoHome
TradeOrGoHome Aug. 3 at 2:40 AM
$SRPT they’re hiring! Let’s go!
1 · Reply
WBinthehouse
WBinthehouse Aug. 3 at 1:49 AM
$CAPR @rogertrades @Markland55 Hiring lobbyists is a great idea. They have great reach in Capitol Hill. Lawmakers who can tap the President. The kids have another option, a drug that repairs and reverses cardiomyopathy. A good sound heart translates to a happy body and soul. The heart is the last to die. A healthy heart lives longer. Yep Deramiocel doesn’t kill and is effective, unlike an approved drug that cost $3.2 million per dose. Elevidys has been in trials and investigated since 2018. A few years later these sick kids still loses ambulation and continues on that spiral of hopelessnes and into a wheelchair. $SRPT has videos of 6 year olds swimming, running upstairs, but compared to untreated kids with DMD the difference is not significant. Otherwise, Doug would be shouting from the top of his longs, Elevidys is effective, it’s effective. Duh it ain’t! Lol it’s the $3.2M. Insurers are pushing back and with the latest deaths, it’s gonna be harder for patients to get.
4 · Reply
MIN17
MIN17 Aug. 3 at 1:47 AM
1 · Reply
twin_dad
twin_dad Aug. 3 at 1:33 AM
0 · Reply
broke_millionaire
broke_millionaire Aug. 3 at 1:14 AM
$SRPT I think shorts are stuck personally
0 · Reply
ValuePlayRunners
ValuePlayRunners Aug. 3 at 12:29 AM
$SRPT I have mine, do you have yours? See everyone at $100 before end of September. One of the easiest investments right now. There will be a lot of newly minted millionaires with the epic run about to start.
1 · Reply
Rockette
Rockette Aug. 2 at 11:17 PM
$SRPT to the moon max thursday
0 · Reply